View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 240 / Ipilimumab 1, Esophageal Cancer, Cycle 4+
Protocol-ID: 2151 V1.1 (Mini), NIVO240/IPIL1, Esophageal Ca, cycle 4+Indication(s)
- Esophageal Cancer (Squamous Cell Carcinoma); ICD-10 C15.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.02.2023